Results 1 to 10 of about 10,579 (219)

Bispecific antibodies for viral immunotherapy [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies.
Elisabeth K. Nyakatura   +2 more
doaj   +4 more sources

VIRAL ANTIBODIES IN PRESCHOOL CHILDREN [PDF]

open access: yesIranian Journal of Public Health, 1974
One hundred sera from children 1 - 6 years of age, representative of a large serum collection, were tested for the prevalence of antibodies against different viruses.
S. Saidi
doaj   +2 more sources

Antibody therapies for the prevention and treatment of viral infections [PDF]

open access: yesnpj Vaccines, 2017
Antibodies are an important component in host immune responses to viral pathogens. Because of their unique maturation process, antibodies can evolve to be highly specific to viral antigens.
Georgina Salazar   +3 more
doaj   +3 more sources

Viral antibodies in multiple sclerosis [PDF]

open access: yesThe Italian Journal of Neurological Sciences, 1982
The sera of 176 MS patients and of 150 healthy adult controls were assayed for antibodies against mumps, rubella, Sendai and herpes simplex viruses, a higher prevalence of measles c.f.a. having already been demonstrated in the MS patients. The CSF of 48 of the MS patients were subjected to the same tests.
S. Barbesti   +3 more
openaire   +3 more sources

Platelet antibodies in viral hepatitis

open access: yesThe Turkish Journal of Pediatrics, 1987
O Hasdal, S Ozsoylu, N Koçak
doaj   +2 more sources

An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.

open access: yesPLoS ONE, 2021
IgA antibodies, which are secreted onto the mucosal surface as secretory IgA antibodies (SIgAs), play an important role in preventing influenza virus infection.
Kaori Sano   +15 more
doaj   +1 more source

Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans

open access: yesViruses, 2021
While SARS-CoV-2 specific neutralizing antibodies have been developed for therapeutic purposes, the specific viral triggers that drive the generation of SARS-CoV-2 specific IgG and IgM antibodies remain only partially characterized.
Shuyi Yang   +4 more
doaj   +1 more source

Viral Antibodies in Diabetes Mellitus [PDF]

open access: yesBMJ, 1969
Sera from 123 patients with diabetes mellitus of recent onset, 155 patients with diabetes of more than two years' duration, and 250 normal persons were collected over a period of two and a half years. All sera were tested for neutralizing antibody to Coxsackie virus types B1-6, and a sample was tested for complement-fixing antibody to a number of viral,
M. L. Kinsley   +4 more
openaire   +2 more sources

Mechanisms of hemagglutinin targeted influenza virus neutralization. [PDF]

open access: yesPLoS ONE, 2013
Human monoclonal antibodies have been identified which neutralize broad spectra of influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere with infectivity.
Boerries Brandenburg   +12 more
doaj   +1 more source

Detection of Anti-Nucleocapsid Antibody in COVID-19 Patients in Bangladesh Is not Correlated with Previous Dengue Infection

open access: yesPathogens, 2021
Background: The assessment of antibody responses to severe acute respiratory syndrome coronavirus-2 is potentially confounded by exposures to flaviviruses. The aims of the present research were to determine whether anti-dengue antibodies affect the viral
Simon D. Lytton   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy